| Migraine |
1 |
1 |
| Adverse Effects |
0 |
0.56 |
| Cyclic Antidepressants |
0 |
0.51 |
| Antidepressant drug |
0 |
0.5 |
| Depression |
0 |
0.38 |
| Receptors |
0 |
0.31 |
| Angiotensin II Receptor Blockade |
0 |
0.27 |
| Patient Safety |
0 |
0.25 |
| Beta-Adrenergic Agonist |
0 |
0.19 |
| Insurance |
0 |
0.19 |
| Preventive Medicine |
0 |
0.19 |
| Epilepsy |
0 |
0.17 |
| Anticonvulsant |
0 |
0.13 |
| Intravenous |
0 |
0.13 |
| Kidney |
0 |
0.13 |
| Memory |
0 |
0.13 |
| Monoclonal Antibody |
0 |
0.13 |
| Nausea |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Referral |
0 |
0.13 |
| Weight Loss |
0 |
0.13 |
| Pregnancy |
0 |
0.12 |
| Generics |
0 |
0.11 |
| Headache |
0 |
0.11 |
| Xerostomia |
0 |
0.09 |
| Constipation |
0 |
0.08 |
| Dentistry and Oral Health |
0 |
0.08 |
| Nephrolithiasis |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |
| Weight Management |
0 |
0.08 |
| Hypertension |
0 |
0.07 |
| Abdomen |
0 |
0.06 |
| Beta Blockers |
0 |
0.06 |
| Biologic Therapy |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Concerns of Elderly |
0 |
0.06 |
| Drug Costs |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Heart |
0 |
0.06 |
| Medicare |
0 |
0.06 |
| Mouth |
0 |
0.06 |
| Orbit |
0 |
0.06 |
| Pain Management |
0 |
0.06 |
| Paresthesia |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Sleep |
0 |
0.06 |
| Weight Gain |
0 |
0.06 |